Thermal burns caused by flames, hot liquids, steam, or heated surfaces can damage the skin, underlying tissues, and microcirculation. Hyperbaric oxygen therapy (HBOT) has been investigated as an adjunctive treatment to improve tissue oxygenation and support wound repair. Although some studies report promising outcomes, current evidence does not establish HBOT as a reliable way to prevent burn progression, eliminate skin grafting, or reduce scarring. It must never replace standard burn care.
Key Takeaways
- Thermal burns can trigger inflammation, edema, impaired blood flow, and progressive tissue injury.
- HBOT increases oxygen dissolved in plasma and may support selected wound-healing processes.
- Clinical findings are promising in some studies but remain inconsistent, with no universally accepted burn-treatment protocol.
- Severe burns require urgent medical assessment. HBOT, if considered, should be coordinated with a qualified burn-care team.
- Home hyperbaric chambers are not established treatments for acute burns and should never delay emergency care.
1. What Are Thermal Burns and How Do They Damage Tissue?
Thermal burns occur when heat damages the skin and potentially deeper structures. Their severity depends on burn depth, total body surface area (TBSA), anatomical location, and associated injuries. Superficial burns affect the outer skin, while deep partial-thickness and full-thickness burns may damage the dermis, blood vessels, nerves, and other tissues.
Jackson’s classic burn-wound model describes three zones. The zone of coagulation is the central area of irreversible thermal injury. Surrounding it, the zone of stasis has reduced blood flow and potentially salvageable tissue. The outer zone of hyperemia generally has better circulation and a greater likelihood of recovery.
During the hours following injury, inflammation and increased capillary permeability can cause edema. Swelling, reduced microcirculation, infection, and inadequate tissue oxygen delivery may contribute to secondary injury, allowing some initially viable tissue to deteriorate.
This process explains the interest in therapies that might improve oxygen availability and limit tissue damage. However, the extent and depth of the burn—not a single TBSA threshold alone—determine the treatment strategy and prognosis.
2. How HBOT May Support Burn Wound Healing
Tissue Oxygenation and Edema Reduction
HBOT involves breathing oxygen at a pressure above normal atmospheric pressure in a specialized chamber. This increases the amount of oxygen dissolved in plasma, potentially improving oxygen availability in tissues with impaired circulation.
Hyperbaric oxygen also causes vasoconstriction, which may help reduce edema while elevated dissolved oxygen supports tissue oxygen delivery. Researchers have therefore investigated whether HBOT could help preserve vulnerable tissue in the zone of stasis. Whether this mechanism consistently translates into better outcomes for burn patients remains uncertain.
Infection Control and Immune Function
Adequate oxygen levels support certain white blood cell functions and contribute to the body’s defense against infection. Oxygen also influences cellular processes involved in tissue repair.
Nevertheless, HBOT is not a substitute for wound cleansing, debridement, appropriate antimicrobial treatment, or surgery when indicated. Its potential antimicrobial effects should not be interpreted as proof that it reliably prevents burn-wound infections.
Angiogenesis and Tissue Repair
Oxygen participates in collagen synthesis, fibroblast activity, epithelial repair, and signaling associated with new blood vessel formation. These mechanisms provide a scientific rationale for studying HBOT in burn recovery.
However, biological plausibility does not establish a clinical benefit. Improved oxygen availability does not automatically mean faster healing, less scarring, or fewer skin grafts.
3. What Does Research Say About HBOT for Thermal Burns?
The clinical evidence remains mixed. A 2026 systematic review in the Journal of Burn Care & Research included 13 studies—five randomized controlled trials, seven cohort studies, and one case-control study—covering 566 patients who received HBOT. The studies varied substantially in burn severity, treatment protocols, and outcome measurements, limiting direct comparisons and definitive conclusions.
Some studies reported shorter hospital stays, faster wound healing, or fewer surgical procedures. Others found no significant differences in outcomes such as mortality, length of hospitalization, infection, or the number of operations. Findings related to mortality were inconsistent, and observational studies cannot reliably establish that HBOT caused the reported differences.
The earlier Cochrane systematic review likewise concluded that the available randomized trials were insufficient to support or refute routine HBOT for thermal burns.
Several important questions remain unresolved:
- Burn wound progression: Can HBOT reliably preserve tissue in the zone of stasis?
- Healing and infection: Does it consistently shorten healing time or reduce infection rates?
- Skin grafts and scarring: Does it improve graft survival or reduce long-term hypertrophic scarring?
- Patient selection: Which burn depths, injury patterns, or clinical circumstances are most likely to benefit?
The Undersea and Hyperbaric Medical Society (UHMS) lists acute thermal burn injury among its recognized HBOT indications. However, this does not mean HBOT is routine treatment for every burn or that all proposed benefits have been conclusively demonstrated. Clinical decisions still require individualized assessment.
4. HBOT Protocols for Thermal Burns
No universally accepted, evidence-based HBOT protocol has been established for routine thermal burn treatment. Published studies have used different pressures, session durations, treatment frequencies, and total numbers of sessions.
A specialist team may consider several factors when evaluating a protocol:
- Treatment pressure and oxygen-delivery method
- Duration and frequency of individual sessions
- Time elapsed since the burn occurred
- Burn depth, TBSA, and overall clinical condition
- Wound progression, response to treatment, and adverse effects
Protocols reported in burn studies have varied considerably, so a single pressure or session schedule should not be presented as universally effective. Protocols used for crush injuries or compromised skin grafts should not automatically be transferred to thermal burns.
If HBOT is considered, it should be integrated into a treatment plan led by qualified clinicians, with access to appropriate monitoring, wound care, and surgical services.
5. HBOT Safety and Standard Burn Management
HBOT carries potential risks, including middle-ear or sinus barotrauma, temporary vision changes, oxygen toxicity, and pressure-related complications. A clinical team must assess contraindications, respiratory status, medication history, and the patient’s ability to tolerate chamber treatment.
These considerations are particularly important for patients with major burns, who may need intensive monitoring, fluid management, respiratory support, or urgent surgery.
Standard burn management remains the priority and may include:
- Assessment of burn depth, TBSA, airway risk, and associated injuries
- Fluid resuscitation and temperature management when indicated
- Wound cleaning, dressings, and debridement
- Infection prevention and appropriate antimicrobial treatment
- Skin grafting or other surgical procedures for deep burns
- Pain management, rehabilitation, and long-term scar care
According to the American Burn Association’s referral guidelines, full-thickness burns, partial-thickness burns involving at least 10% TBSA, and deep burns affecting the face, hands, feet, genitalia, perineum, or major joints warrant immediate consultation with consideration for transfer to a burn center. Suspected inhalation injury also requires urgent assessment.
6. Can a Hyperbaric Chamber Be Used for Burn Treatment?
For patients researching hyperbaric oxygen equipment, the most important distinction is between medically supervised HBOT and consumer-oriented home chambers.
Acute burn treatment is a hospital-based process. If a specialist considers HBOT, the facility must be able to deliver the prescribed treatment safely, monitor the patient, manage emergencies, and coordinate care with burn surgeons and wound-care professionals.
When evaluating a chamber for a legitimate clinical application, relevant factors include its rated operating pressure, oxygen-delivery system, safety certification, monitoring capabilities, emergency access, maintenance requirements, and suitability for the intended indication. Equipment specifications alone do not establish clinical effectiveness.
Home hyperbaric chambers should not be marketed or relied upon as proven treatments for acute burns, burn-wound rescue, or scar prevention. People with serious burns should never delay emergency care or transfer to a burn center to access a chamber.
Conclusion
HBOT has a plausible biological rationale in burn care because it increases dissolved oxygen and may influence edema, inflammation, and tissue repair. However, current research does not establish that it reliably prevents necrosis, avoids skin grafting, or reduces scarring after thermal burns. Established burn management remains essential, and any adjunctive HBOT treatment should be considered by a qualified clinical team. Choosing appropriate hyperbaric equipment begins with the intended medical indication, the required level of supervision, and the evidence supporting its use—not simply the chamber’s pressure rating.
